Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). (2019)
Attributed to:
Lifecourse Determinants of Bone and Joint Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s40266-019-00667-8
PubMed Identifier: 31073927
Publication URI: http://europepmc.org/abstract/MED/31073927
Type: Journal Article/Review
Volume: 36
Parent Publication: Drugs & aging
Issue: Suppl 1
ISSN: 1170-229X